Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Core Laboratories Q3 2023 Adj EPS $0.22, Inline, Sales $125.34M Miss $129.97M Estimate

Author: Benzinga Newsdesk | November 01, 2023 05:47pm
Core Laboratories (NYSE:CLB) reported quarterly earnings of $0.22 per share which met the analyst consensus estimate. This is a 22.22 percent increase over earnings of $0.18 per share from the same period last year. The company reported quarterly sales of $125.34 million which missed the analyst consensus estimate of $129.97 million by 3.56 percent. This is a 0.49 percent decrease over sales of $125.97 million the same period last year.

Posted In: CLB

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist